×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!

PAREXEL CEO Josef H. von Rickenbach Rings Bell at NASDAQ Market Opening

June 10, 2012
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and its Chairman of the Board and Chief Executive Officer, Josef H. von Rickenbach, rang the opening bell at the NASDAQ MarketSite in Times Square in New York City on May 30, 2012. The event was part of a series of activities celebrating the 30th anniversary of PAREXEL, which was founded by Mr. von Rickenbach and Dr. Sayigh in 1982.
Previous Video
Mario Papillon, VP, PAREXEL Speaks About Notable Trends in CRO Partnering
Mario Papillon, VP, PAREXEL Speaks About Notable Trends in CRO Partnering

Mario Papillon, VP Strategic Account Leader from PAREXEL talks about notable trends in CRO partnering inclu...

Next Video
Josh Schultz, Corporate VP Strategic Partnerships, recorded at Partnerships in Clinical Trials
Josh Schultz, Corporate VP Strategic Partnerships, recorded at Partnerships in Clinical Trials

Josh Schultz of PAREXEL discusses: What biopharmaceutical companies are looking for, major benefits and cor...